Zeria

Pfizer and Gero collaborate on fibrotic disease research

and holds commercial rights in the US and Japan. ... Pfizer will hold a 25% stake in the new business and will maintain commercial rights outside the US and Japan.

Biogen and Eisai’s Alzheimer’s drug receives FDA accelerated approval

We will continue to actively cooperate with the FDA's review.”. The Japanese company said it also planned to apply for marketing authorisation for Leqembi in Japan and the EU by

Takeda therapy shows promise in rare blood clotting disorder

forms, and by the European Medicines Agency and Japan’s Ministry of Health, Labour and Welfare for the treatment of TTP.

Moderna to acquire OriCiro Genomics for $85m

Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch.

Eisai and Washington University to develop neurodegenerative disease therapies

The collaboration combines Washington University’s expertise in research focused on neurodegenerative diseases with the Japan-based pharma’s experience in drug discovery and development.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]